Moreover, the strong correlation between CD79A and risk score, B cells, T cells, TIGIT, BTLA, CD27, and TNFRSF17 revealed the crucial role of CD79A in regulating the tumor microenvironment (TME) in LUAD patients. Here, CD79A is linked to neoplasm.